Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Baudax Bio Inc (BXRX)

Baudax Bio Inc (BXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Global Rheumatoid Arthritis Drugs Market Expected To Hit US$ 70 Billion By 2030 FinancialNewsMedia - Fri Dec 30, 2022

EQNX::TICKER_START (NASDAQ:SILO),(NASDAQ:BXRX),(NASDAQ:HOTH),(NASDAQ:KALA),(NASDAQ:NUWE) EQNX::TICKER_END

NUWE : 0.1300 (-2.62%)
BXRX : 0.0218 (+7.39%)
KALA : 3.54 (-1.94%)
HOTH : 1.3600 (+92.01%)
SILO : 6.01 (-1.72%)
Global Rheumatoid Arthritis Drugs Market Expected To Hit US$ 70 Billion By 2030 PR Newswire - Fri Dec 30, 2022

/PRNewswire/ -- According to the Centers for Disease Control and Prevention, arthritis affects approximately one in every four Americans, or 58.5 million...

NUWE : 0.1300 (-2.62%)
BXRX : 0.0218 (+7.39%)
KALA : 3.54 (-1.94%)
HOTH : 1.3600 (+92.01%)
SILO : 6.01 (-1.72%)
Baudax Bio (NASDAQ: BXRX) Launches Phase 2 Clinical Trial Testing BX1000 for Neuromuscular Blockade in Patients Undergoing Surgery Spotlight Growth - Fri Dec 9, 2022

Baudax Bio, Inc. (NASDAQ: BXRX) is engaged as a pharmaceutical company, which is focused on developing innovative products for use

BXRX : 0.0218 (+7.39%)
Wall Street - NYSE Full View
Pre-Market Brief: Stocks Move Higher Ahead of Key U.S. PPI Data Barchart - Fri Dec 9, 2022

December S&P 500 futures (ESZ22) are trending up +0.23% this morning after three major US benchmark indices snapped a losing streak and closed higher on Thursday as market participants cheered a rise in...

LULU : 105.43 (-5.67%)
AVGO : 392.13 (-4.67%)
BXRX : 0.0218 (+7.39%)
JAZZ : 225.92 (+0.56%)
DOCU : 42.71 (-1.75%)
ESZ22 : 3,871.47s (-0.66%)
Baudax Bio Reports Second Quarter 2022 Financial Results and Business Highlights Globe Newswire - Thu Aug 11, 2022

ANJESO® Net Product Revenue Up 49% Year-Over-Year; Vials Sold to End-Users Up 67% Year-Over-Year Dosing Complete in the First Cohort of the Phase I...

BXRX : 0.0218 (+7.39%)
Cosette Pharmaceuticals Appoints Rick Casten as CFO Amid Transformational Growth Business Wire - Wed Jul 6, 2022

Cosette Pharmaceuticals, Inc., a New Jersey-based specialty pharmaceutical company, today announced the appointment of Rick Casten as Chief Financial Officer (CFO), bolstering its executive leadership...

BXRX : 0.0218 (+7.39%)

Barchart Exclusives

The Big Tech Investment Cycle is Shifting, and Chevron Just Wrote the Blueprint for the AI Power Trade. Barchart - Mon Jun 22, 7:52PM CDT
The new partnership between energy giant Chevron and hyperscaler Microsoft highlights that the next phase of the artificial intelligence trade is plugging directly into the power grid. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.